NDC properties for NDC 9 55513-399
NDC item 55513039901
NDC 9 | 55513-399 |
---|---|
NDC 10 | 55513-399-01 |
NDC Item | 55513039901 |
packaging | 1 SYRINGE in 1 CARTON (55513-399-01) / .2 mL in 1 SYRINGE |
BLA | BLA761024 |
FDA SPL set id | 807577 |
Labeler | Amgen Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | BLA |
Marketing effective time low | 2023-08-14 |
Marketing status | ACTIVE |
NDC item 72511039901
NDC 9 | 72511-399 |
---|---|
NDC 10 | 72511-399-01 |
NDC Item | 72511039901 |
packaging | 1 SYRINGE in 1 CARTON (72511-399-01) / .2 mL in 1 SYRINGE |
BLA | BLA761024 |
FDA SPL set id | 828840 |
Labeler | Amgen USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | BLA |
Marketing effective time low | 2024-11-08 |
Marketing status | ACTIVE |
NDC item 84612039901
NDC 9 | 84612-399 |
---|---|
NDC 10 | 84612-399-01 |
NDC Item | 84612039901 |
packaging | 1 SYRINGE in 1 CARTON (84612-399-01) / .2 mL in 1 SYRINGE |
BLA | BLA761024 |
FDA SPL set id | 858781 |
Labeler | Optum Health Solutions (Ireland) Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | BLA |
Marketing effective time low | 2025-01-01 |
Marketing status | ACTIVE |